Advancements in hemostats have brought about a transformative impact on surgical care and patient outcomes. These innovations in hemostatic agents have revolutionized the way bleeding is managed during surgical procedures. With improved effectiveness, safety, and ease of use, these advanced hemostats are helping surgeons achieve better control over bleeding, leading to reduced complications and enhanced patient recovery. The development of novel sealants, patches, and topical agents has significantly improved hemostasis, providing surgeons with valuable tools to ensure successful surgical outcomes and improved patient well-being.
Access Full Report: https://www.databridgemarketresearch.com/fr/reports/global-hemostats-market
Data Bridge Market Research analyses that the Global Hemostats Market is valued at USD 2.92 billion in 2021 and is expected to reach USD 4.65 billion by 2029, registering a CAGR of 6.85% during the forecast period of 2022 to 2029. The rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and gastrointestinal disorders has contributed to the demand for hemostatic products. These conditions often require surgical interventions, creating a higher demand for hemostatic agents to minimize bleeding and improve patient outcomes.
Key Findings of the Study
The increasing geriatric population is expected to drive the market's growth rate
The growing geriatric population has fueled the expansion of the hemostats market due to their increased susceptibility to age-related diseases and the need for surgical interventions. Elderly individuals commonly experience coagulation disorders and have fragile blood vessels, making them more prone to bleeding during surgeries. Hemostatic agents play a crucial role in controlling and minimizing bleeding in these patients, improving surgical outcomes, and reducing complications. As the elderly population continues to grow, the demand for hemostatic products rises, driving the market's expansion to cater to their specific needs.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
CR Bard, Inc. (U.S.), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Integra LifeSciences (U.S.), Marine Polymer Technologies, Inc. (U.S.), Teleflex (US), Ethicon, Inc. (U.S.), Pfizer, Inc. (U.S.), Z-Medica LLC (U.S.), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (U.S.), Stryker (U.S.), and Integra Lifesciences Corporation(US)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The global hemostats market is segmented on the basis of product type, formulation, application, indication and end-user.
- On the basis of product type, the hemostats market is segmented into thrombin based, combination, oxidized regenerated cellulose based, gelatin based and collagen based hemostat.
- On the basis of formulation, the hemostats market is segmented into matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats.
- On the basis of application, the hemostats market is segmented into orthopedic, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery and gynecological surgery.
- On the basis of indication, the hemostats market is segmented into wound closure and surgery.
- On the basis of end-user into hospitals, clinics, ambulatory centers, community healthcare and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major global hemostats market players in global hemostats market are CR Bard, Inc. (U.S.), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Integra LifeSciences (U.S.), Marine Polymer Technologies, Inc. (U.S.), Teleflex (US)
Market Developments
- In February 2021, EndoClot Plus, Inc. recently achieved a significant milestone as the U.S. Food and Drug Administration (FDA) granted clearance for their EndoClot Polysaccharide Hemostatic System. This cutting-edge product is designed to aid gastroenterologists in effectively and swiftly preventing bleeding.
- In July 2021, Medcura, Inc., in collaboration with ASO LLC, has introduced Rapid-Seal, a novel class of antibacterial hemostatic gel. This innovative product addresses the market's need for a transparent gel that can be conveniently applied to injuries.
- In March 2020, The Institute of Nano Science and Technology (INST), an autonomous institute operating under the Department of Science & Technology, has successfully developed a 'hemostat' material based on starch. This innovative material aids in halting blood flow by enhancing the concentration of natural clotting factors present in the blood.
Regional Analysis
Geographically, the countries covered in the global hemostats market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
Asia-Pacific is the dominating region in the global hemostats market during the forecast period 2022 - 2029
In 2022, Asia-Pacific dominated the global hemostats market due to the rising number of surgeries performed in the region has created a higher demand for hemostatic products. As surgical procedures increase, the need for effective blood control during and after surgeries becomes paramount. The development of technologically advanced hemostatic products has further fueled market growth. These innovative products offer improved hemostatic capabilities, allowing for better control of bleeding, particularly in trauma-related procedures.
For more detailed information about the global hemostats market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-hemostats-market
